China Medicine Corporation (CHME) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Distribution Branche. Der Hauptsitz des Unternehmens ist in Guangzhou, China. Der aktuelle CEO ist Senshan Yang.
CHME hat IPO-Datum 2006-11-30, 281 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $474.24K.
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
